Dr. Michael Gnant (@michaelgnant) 's Twitter Profile
Dr. Michael Gnant

@michaelgnant

Surgeon. Physician Scientist. Clinical Trials. @MedUni_Wien @ABCSGVienna. Arzt. Chirurg. Dad. Streben nach Weisheit. Cogito ergo sum. Tweets&opinions are mine.

ID: 1227966718636625922

linkhttp://www.michaelgnant.at calendar_today13-02-2020 14:44:24

1,1K Tweet

1,1K Followers

286 Following

Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

The #SGBCC2025 experts panel The largest panel to date One third of the experts are joining for the first time, and over half are women Terrific discussions ensured SGBCC

The #SGBCC2025 experts panel

The largest panel to date

One third of the experts are joining for the first time, and over half are women

Terrific discussions ensured 

<a href="/SG_BCC/">SGBCC</a>
iBreastBook (@ibreastbook) 's Twitter Profile Photo

It's great to be an invited Guest by Dr. Michael Gnant to one of the most important conferences in Breast Cancer (St Gallen Breast Cancer Conference) SGBCC as a Social Media Ambassador. Great talks and debates with thousands of attendees in the Beautiful City of #Vienna We had

It's great to be an invited Guest by <a href="/MichaelGnant/">Dr. Michael Gnant</a>  to one of the most important conferences in Breast Cancer (St Gallen Breast Cancer Conference)  <a href="/SG_BCC/">SGBCC</a>  as a Social Media Ambassador. Great talks and debates with thousands of attendees in the Beautiful City of #Vienna 
We had
Matteo Lambertini, MD PhD (@matteolambe) 's Twitter Profile Photo

What a fantastic talk by super VIRGINIA KAKLAMANI at SGBCC #SGBCC2025 conference highlighting how a meeting like SABCS can help reducing #BreastCancer burden…so much looking forward to #SABCS25 🤩😍💪 Dr. Michael Gnant G Curigliano MD PhD OncoAlert

What a fantastic talk by super <a href="/VKaklamani/">VIRGINIA KAKLAMANI</a> at <a href="/SG_BCC/">SGBCC</a> #SGBCC2025 conference highlighting how a meeting like <a href="/SABCSSanAntonio/">SABCS</a> can help reducing #BreastCancer burden…so much looking forward to #SABCS25 🤩😍💪
<a href="/MichaelGnant/">Dr. Michael Gnant</a> <a href="/curijoey/">G Curigliano MD PhD</a> <a href="/OncoAlert/">OncoAlert</a>
Stephanie Graff, MD, FACP, FASCO (@drsgraff) 's Twitter Profile Photo

Ground Rules, à la Harold J. Burstein, MD, PhD, FASCO SGBCC 📁 case based 🚫 you can’t answer “I would put them on a trial…” (that’s always the answer) 🦓 Answer based on “usual” not “that one case 7 years ago…” (no zebras) #SGBCC2025

Ground Rules, à la <a href="/DrHBurstein/">Harold J. Burstein, MD, PhD, FASCO</a> <a href="/SG_BCC/">SGBCC</a> 
📁 case based
🚫 you can’t answer “I would put them
on a trial…” (that’s always the answer)
🦓 Answer based on “usual” not “that one case 7 years ago…” (no zebras)
#SGBCC2025
Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

The largest multidisciplinary breast oncology tumor board in the world is ready to build consensus. Let the last day of #SGBCC2025 begin!

The largest multidisciplinary breast oncology tumor board in the world is ready to build consensus.

Let the last day of #SGBCC2025 begin!
SGBCC (@sg_bcc) 's Twitter Profile Photo

Consensus Session 🎤✨ Today marks the end of #SGBCC2025, closing with the St. Gallen International Consensus Session. Results will shape the upcoming St.Gallen International Breast Cancer Consensus Guidelines. #FromResearchToPractice #BreastCancerResearch #ConsensusGuidelines

Consensus Session 🎤✨

Today marks the end of #SGBCC2025, closing with the St. Gallen International Consensus Session. Results will shape the upcoming St.Gallen International Breast Cancer Consensus Guidelines. 

#FromResearchToPractice #BreastCancerResearch #ConsensusGuidelines
SGBCC (@sg_bcc) 's Twitter Profile Photo

That’s a wrap on #SGBCC2025! 👏 Thank you to everyone who made these four days unforgettable and helped make #SGBCC2025 a success. Save the date for #SGBCC2027: March 17–20, 2027! 📅 #BreastCancerResearch #FromResearchToPractice

Dr. Michael Gnant (@michaelgnant) 's Twitter Profile Photo

Honored and humbled by another great collaboration: I will help and mentor young talents from Dalian Medical University in the coming three years - another successful way improving breast cancer care globally! MedUni Wien ABCSG SGBCC

Honored and humbled by another great collaboration: I will help and mentor young talents from Dalian Medical University in the coming three years - another successful way improving breast cancer care globally! <a href="/MedUni_Wien/">MedUni Wien</a> <a href="/ABCSGVienna/">ABCSG</a> <a href="/SG_BCC/">SGBCC</a>
Dr. Michael Gnant (@michaelgnant) 's Twitter Profile Photo

Not that often that someone from Vienna is impressed by a concert hall elsewhere… But Hamburg‘s Elbphilharmonie with it’s marvelous architecture and phenomenal acoustics is always worth a visit!

Not that often that someone from Vienna is impressed by a concert hall elsewhere… But Hamburg‘s Elbphilharmonie with it’s marvelous architecture and phenomenal acoustics is always worth a visit!
Dr. Michael Gnant (@michaelgnant) 's Twitter Profile Photo

Fascinating Puglia: marvelous landscape, rich history+cultural heritage: Altamura,Matera,Noci,Ostuni, MartinaFranca,Cisternino,Locorotondo, Alberobello,Savelletri, TorreCanne,Lecce, Acaia,Galatina,Gallipoli, Manduria, Monopoli, PolignanoaMare,Giovinazzo, CasteldelMonte,Bari.

Fascinating Puglia: marvelous landscape, rich history+cultural heritage: Altamura,Matera,Noci,Ostuni, MartinaFranca,Cisternino,Locorotondo, Alberobello,Savelletri, TorreCanne,Lecce, Acaia,Galatina,Gallipoli, Manduria, Monopoli, PolignanoaMare,Giovinazzo, CasteldelMonte,Bari.
ABS (@absgbi) 's Twitter Profile Photo

And we're off! Thank you Dr. Michael Gnant for that thought-provoking lecture on the future of #BreastCancer treatment - a fantastic way to kick of #ABSConference2025!

And we're off! Thank you <a href="/MichaelGnant/">Dr. Michael Gnant</a> for that thought-provoking lecture on the future of #BreastCancer treatment - a fantastic way to kick of #ABSConference2025!
Dr. Michael Gnant (@michaelgnant) 's Twitter Profile Photo

Attending ASCO every year for 3 decades - breakthrough oncology innovation presented, 60.000 attendees in Chicago: good news to cancer patients worldwide! Honored to be invited again to discuss some of the new data in breast oncology! ⁦ABCSG⁩ ⁦MedUni Wien

Attending ASCO every year for 3 decades - breakthrough oncology innovation presented, 60.000 attendees in Chicago: good news to cancer patients worldwide! Honored to be invited again to discuss some of the new data in breast oncology! ⁦<a href="/ABCSGVienna/">ABCSG</a>⁩ ⁦<a href="/MedUni_Wien/">MedUni Wien</a>⁩
Matteo Lambertini, MD PhD (@matteolambe) 's Twitter Profile Photo

Great discussion by Dr. Michael Gnant from ABCSG (chair of SGBCC) to end the oral abstract early #BreastCancer session at #ASCO25: how to optimize adjuvant endocrine therapy in premenopausal patients 👏👏👏 OncoAlert ASCO

Great discussion by <a href="/MichaelGnant/">Dr. Michael Gnant</a> from <a href="/ABCSGVienna/">ABCSG</a> (chair of <a href="/SG_BCC/">SGBCC</a>) to end the oral abstract early #BreastCancer session at #ASCO25: how to optimize adjuvant endocrine therapy in premenopausal patients 👏👏👏 
<a href="/OncoAlert/">OncoAlert</a> <a href="/ASCO/">ASCO</a>
eChinaHealth (@echinahealth) 's Twitter Profile Photo

eChinaHealth and Hengrui Pharmaceutical partnered together during ASCO 2024 and organized the "DANN-Dalpiciclib, Breakthrough in Early Breast Cancer" dialogue between Chinese and global physicians in Chicago. William Gradishar, MD Dr. Michael Gnant

eChinaHealth and Hengrui Pharmaceutical partnered together during ASCO 2024 and organized the "DANN-Dalpiciclib, Breakthrough in Early Breast Cancer" dialogue between Chinese and global physicians in Chicago.

<a href="/DrWGradishar/">William Gradishar, MD</a> <a href="/MichaelGnant/">Dr. Michael Gnant</a>
Dr. Michael Gnant (@michaelgnant) 's Twitter Profile Photo

Important reading for all clinical trialists: always be aware of (and transparent about!) the event „classification“ for your study endpoints. Great work by ABCSG led by Dominik Hlauschek! doi.org/10.1016/j.esmo… MedUni Wien

Important reading for all clinical trialists: always be aware of (and transparent about!) the event „classification“ for your study endpoints. Great work by <a href="/ABCSGVienna/">ABCSG</a> led by Dominik Hlauschek! doi.org/10.1016/j.esmo… <a href="/MedUni_Wien/">MedUni Wien</a>